Research and innovation news

Staff at MFT, already caring for patients on the frontline, are now helping fight the battle against COVID-19 by taking part in research

Our first patient has taken part in a research trial testing whether SNG001 – a drug treatment administered via a nebuliser – could be a potential treatment for COVID-19 (coronavirus).

MFT has recruited more than 400 patients to research trials in an attempt to better understand and treat COVID-19.

A partnership of Manchester’s NHS and academic organisations will continue accelerating health research after once again receiving the prestigious Academic Health Science Centre (AHSC) designation.

The first MFT patient has taken part in a research trial which is testing potential treatments for COVID-19 (coronavirus).

In an unprecedented move, scientists and clinicians across Greater Manchester have formed a Rapid Response Research Group to find ways to beat COVID-19 and save lives.

The expansion of Manchester’s leading health innovation campus, Citylabs, has been given the green light following the approval of the recently submitted planning application.

Due to concentrated efforts in support of COVID-19 research we are making changes to the way we conduct research